Drug Repositioning Service Global Market Report 2026

Description

Drug repositioning service focuses on systematically discovering new therapeutic applications for existing drugs, enabling pharmaceutical companies to enhance the value of their current drug portfolios while reducing the risks linked to developing entirely new compounds. By utilizing existing clinical data and research, drug repositioning services help optimize the drug development process, considerably lowering the time and cost needed to deliver effective treatments to patients.

The main types of drug repositioning services include generic drugs and drugs that failed in clinical trials. Generic drugs are medications that contain the same active ingredients, strength, dosage form, and therapeutic effect as brand-name drugs but are generally available at lower costs. The therapeutic areas include oncology, neurology, infectious diseases, cardiovascular diseases, and other therapeutic areas. These are utilized by various end users, including pharmaceutical companies, biotechnology firms, contract research organizations (CROs), academic research institutions, hospitals, and ambulatory surgical centers.

Tariffs are impacting the drug repositioning service market by increasing costs associated with imported computational infrastructure, specialized software licenses, laboratory reagents, and cross-border research services. Pharmaceutical and biotechnology companies in North America and Europe are most affected due to reliance on global data platforms and outsourced research activities, while Asia-Pacific faces increased costs for collaborative research services. These tariffs are elevating overall project expenses and slowing multinational repositioning programs. However, they are also encouraging regional research partnerships, domestic service provider growth, and localized drug development strategies.

The drug repositioning service market research report is one of a series of new reports from The Business Research Company that provides drug repositioning service market statistics, including drug repositioning service industry global market size, regional shares, competitors with a drug repositioning service market share, detailed drug repositioning service market segments, market trends and opportunities, and any further data you may need to thrive in the drug repositioning service industry. This drug repositioning service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug repositioning service market size has grown strongly in recent years. It will grow from $34.2 billion in 2025 to $36.19 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing pharmaceutical r&d costs, availability of extensive legacy drug data, rising number of failed clinical trials, growing demand for faster drug development cycles, early adoption of computational drug discovery.

The drug repositioning service market size is expected to see strong growth in the next few years. It will grow to $45.92 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing demand for cost-efficient drug development, rising adoption of ai-driven discovery tools, growing focus on rare and orphan diseases, expansion of data-driven clinical research, increasing regulatory acceptance of repurposed drugs. Major trends in the forecast period include increasing use of ai-based drug repurposing platforms, rising focus on failed clinical drug re-evaluation, growing integration of real-world evidence in drug discovery, expansion of precision medicine-oriented repositioning, enhanced collaboration between pharma and cros.

The increase in healthcare expenditures is expected to drive the growth of the drug repositioning service market in the coming years. Healthcare expenditures refer to the total funds allocated to health services, including prevention, treatment, rehabilitation, and administration. These expenditures are rising mainly due to higher medical costs fueled by technological advancements and growing demand for healthcare services. Increased healthcare spending benefits drug repositioning services, as more funding enables additional clinical trials and research, speeding up the discovery of new therapeutic applications for existing drugs. For example, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a notable increase of 5.6% in nominal terms from 2022 to 2023. Therefore, the rise in healthcare expenditures is contributing to the growth of the drug repositioning service market.

Major companies operating in the drug repositioning service market are emphasizing the use of artificial intelligence (AI) in drug repositioning, such as computational drug repositioning systems, which systematically identify new therapeutic uses for existing drugs through AI-driven analysis of literature and biological data. A computational drug repositioning system is a technology-based platform that utilizes artificial intelligence, machine learning, and data mining to systematically analyze existing drugs, compounds, and biological data. For example, in November 2024, UBE and FRONTEO, Japanese companies, initiated a co-creation project. The co-creation project provides a collaborative framework that combines expertise from both UBE and FRONTEO to advance drug repositioning efforts. It facilitates seamless interaction between dry research (data analysis) and wet research (biological testing), enhancing the transition from hypothesis generation to experimental validation. By leveraging FRONTEO's AI-driven Drug Discovery AI Factory and KIBIT technology, the project systematically uncovers previously unreported relationships between diseases and molecules.

In January 2024, Cosmos Health Inc., a US-based healthcare group, acquired the Cloudscreen platform from Cloudpharm P.C. for an undisclosed amount. Through this acquisition, Cosmos Health Inc. aims to advance drug repurposing initiatives by utilizing Cloudscreen's AI platform to identify new therapeutic applications for existing drugs more effectively. Cloudpharm P.C. is a Greece-based company that provides drug repositioning services.

Major companies operating in the drug repositioning service market are Recursion Pharmaceuticals Inc., Excelra, LifeArc, Cosmos Health Inc., Fios Genomics, Insilico Medicine Inc., Melior Discovery, Delta4, Acubiosys, VeriSIM Life, BioXcel Therapeutics Inc., Pharnext S.S., NuMedii, GVK Biosciences, Plex Research, Paradigm Biopharmaceuticals, BenevolentAI Limited

North America was the largest region in the drug repositioning service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug repositioning service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug repositioning service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug repositioning service market consists of revenues earned by entities by providing services such as target validation, pharmacovigilance support, formulation optimization, drug combination analysis, and post-marketing surveillance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Repositioning Service Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug repositioning service market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug repositioning service ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug repositioning service market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Type: Generic Drugs; Clinical Trial Failed Drugs
2) By Therapeutic Area: Oncology; Neurology; Infectious Diseases; Cardiovascular Diseases; Other Therapeutic Area
3) By End-User: Pharmaceutical Companies; Biotechnology Firms; Contract Research Organizations (CROs); Academic Research Institutions; Hospitals And Ambulatory Surgical Centers.
Subsegments:
1) By Generic Drugs: Small Molecule Drugs; Biologics; Biosimilars; Peptide-Based Drugs
2) By Clinical Trial Failed Drugs: Phase I Failed Drugs; Phase II Failed Drugs; Phase III Failed Drugs; Safety-Related Failed Drugs; Efficacy-Related Failed Drugs
Companies Mentioned: Recursion Pharmaceuticals Inc.; Excelra; LifeArc; Cosmos Health Inc.; Fios Genomics; Insilico Medicine Inc.; Melior Discovery; Delta4; Acubiosys; VeriSIM Life; BioXcel Therapeutics Inc.; Pharnext S.S.; NuMedii; GVK Biosciences; Plex Research; Paradigm Biopharmaceuticals; BenevolentAI Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH4MDRSE07_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Drug Repositioning Service Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Drug Repositioning Service Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Drug Repositioning Service Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Drug Repositioning Service Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Artificial Intelligence & Autonomous Intelligence
- 4.1.2 Biotechnology, Genomics & Precision Medicine
- 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.4 Industry 4.0 & Intelligent Manufacturing
- 4.1.5 Fintech, Blockchain, Regtech & Digital Finance
4.2. Major Trends
- 4.2.1 Increasing Use Of Ai-Based Drug Repurposing Platforms
- 4.2.2 Rising Focus On Failed Clinical Drug Re-Evaluation
- 4.2.3 Growing Integration Of Real-World Evidence In Drug Discovery
- 4.2.4 Expansion Of Precision Medicine-Oriented Repositioning
- 4.2.5 Enhanced Collaboration Between Pharma And Cros

5. Drug Repositioning Service Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies
5.2 Biotechnology Firms
5.3 Contract Research Organizations
5.4 Academic Research Institutions
5.5 Hospitals And Ambulatory Surgical Centers

6. Drug Repositioning Service Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug Repositioning Service Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Drug Repositioning Service PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Drug Repositioning Service Market Size, Comparisons And Growth Rate Analysis
7.3. Global Drug Repositioning Service Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Drug Repositioning Service Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug Repositioning Service Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug Repositioning Service Market Segmentation

9.1. Global Drug Repositioning Service Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Generic Drugs, Clinical Trial Failed Drugs
9.2. Global Drug Repositioning Service Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Other Therapeutic Area
9.3. Global Drug Repositioning Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations (CROs), Academic Research Institutions, Hospitals And Ambulatory Surgical Centers
9.4. Global Drug Repositioning Service Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Small Molecule Drugs, Biologics, Biosimilars, Peptide-Based Drugs
9.5. Global Drug Repositioning Service Market, Sub-Segmentation Of Clinical Trial Failed Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Phase I Failed Drugs, Phase II Failed Drugs, Phase III Failed Drugs, Safety-Related Failed Drugs, Efficacy-Related Failed Drugs

10. Drug Repositioning Service Market Regional And Country Analysis

10.1. Global Drug Repositioning Service Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Drug Repositioning Service Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug Repositioning Service Market

11.1. Asia-Pacific Drug Repositioning Service Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug Repositioning Service Market

12.1. China Drug Repositioning Service Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug Repositioning Service Market

13.1. India Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug Repositioning Service Market

14.1. Japan Drug Repositioning Service Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug Repositioning Service Market

15.1. Australia Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug Repositioning Service Market

16.1. Indonesia Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug Repositioning Service Market

17.1. South Korea Drug Repositioning Service Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug Repositioning Service Market

18.1. Taiwan Drug Repositioning Service Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug Repositioning Service Market

19.1. South East Asia Drug Repositioning Service Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug Repositioning Service Market

20.1. Western Europe Drug Repositioning Service Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug Repositioning Service Market

21.1. UK Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug Repositioning Service Market

22.1. Germany Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug Repositioning Service Market

23.1. France Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug Repositioning Service Market

24.1. Italy Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug Repositioning Service Market

25.1. Spain Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug Repositioning Service Market

26.1. Eastern Europe Drug Repositioning Service Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug Repositioning Service Market

27.1. Russia Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug Repositioning Service Market

28.1. North America Drug Repositioning Service Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug Repositioning Service Market

29.1. USA Drug Repositioning Service Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug Repositioning Service Market

30.1. Canada Drug Repositioning Service Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug Repositioning Service Market

31.1. South America Drug Repositioning Service Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug Repositioning Service Market

32.1. Brazil Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug Repositioning Service Market

33.1. Middle East Drug Repositioning Service Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug Repositioning Service Market

34.1. Africa Drug Repositioning Service Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Drug Repositioning Service Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug Repositioning Service Market Regulatory and Investment Landscape

36. Drug Repositioning Service Market Competitive Landscape And Company Profiles

36.1. Drug Repositioning Service Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Drug Repositioning Service Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Drug Repositioning Service Market Company Profiles
- 36.3.1. Recursion Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Excelra Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. LifeArc Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Cosmos Health Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Fios Genomics Overview, Products and Services, Strategy and Financial Analysis

37. Drug Repositioning Service Market Other Major And Innovative Companies

Insilico Medicine Inc., Melior Discovery, Delta4, Acubiosys, VeriSIM Life, BioXcel Therapeutics Inc., Pharnext S.S., NuMedii, GVK Biosciences, Plex Research, Paradigm Biopharmaceuticals, BenevolentAI Limited

38. Global Drug Repositioning Service Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug Repositioning Service Market

40. Drug Repositioning Service Market High Potential Countries, Segments and Strategies

40.1 Drug Repositioning Service Market In 2030 - Countries Offering Most New Opportunities
40.2 Drug Repositioning Service Market In 2030 - Segments Offering Most New Opportunities
40.3 Drug Repositioning Service Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer